Literature DB >> 15680263

Acetylcholine in the accumbens is decreased by diazepam and increased by benzodiazepine withdrawal: a possible mechanism for dependency.

Pedro Rada1, Bartley G Hoebel.   

Abstract

Diazepam is a benzodiazepine used in the treatment of anxiety, insomnia and seizures, but with the potential for abuse. Like the other benzodiazepine anxiolytics, diazepam does not increase dopamine in the nucleus accumbens. This raises the question as to which other neurotransmitter systems are involved in diazepam dependence. The goal was to monitor dopamine and acetylcholine simultaneously following acute and chronic diazepam treatment and after flumazenil-induced withdrawal. Rats were prepared with microdialysis probes in the nucleus accumbens and given diazepam (2, 5 and 7.5 mg/kg) acutely and again after chronic treatment. Accumbens dopamine and acetylcholine decreased, with signs of tolerance to the dopamine effect. When these animals were put into the withdrawal state with flumazenil, there was a significant rise in acetylcholine (145%, P<0.001) with a smaller significant rise in dopamine (124%, P<0.01). It is suggested that the increase in acetylcholine release, relative to dopamine, is a neural component of the withdrawal state that is aversive.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15680263     DOI: 10.1016/j.ejphar.2004.12.016

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  11 in total

Review 1.  The role of acetylcholine in cocaine addiction.

Authors:  Mark J Williams; Bryon Adinoff
Journal:  Neuropsychopharmacology       Date:  2007-10-10       Impact factor: 7.853

2.  Dose-related effects of the acetylcholinesterase inhibitor tacrine on cocaine and food self-administration in rats.

Authors:  Kenneth Grasing; Shuangteng He; Yungao Yang
Journal:  Psychopharmacology (Berl)       Date:  2007-10-05       Impact factor: 4.530

Review 3.  Evidence for sugar addiction: behavioral and neurochemical effects of intermittent, excessive sugar intake.

Authors:  Nicole M Avena; Pedro Rada; Bartley G Hoebel
Journal:  Neurosci Biobehav Rev       Date:  2007-05-18       Impact factor: 8.989

4.  Diazepam Concurrently Increases the Frequency and Decreases the Amplitude of Transient Dopamine Release Events in the Nucleus Accumbens.

Authors:  Scott A Schelp; Zachary D Brodnik; Dylan R Rakowski; Katherine J Pultorak; Asha T Sambells; Rodrigo A España; Erik B Oleson
Journal:  J Pharmacol Exp Ther       Date:  2017-10-20       Impact factor: 4.030

Review 5.  A threshold model for opposing actions of acetylcholine on reward behavior: Molecular mechanisms and implications for treatment of substance abuse disorders.

Authors:  Kenneth Grasing
Journal:  Behav Brain Res       Date:  2016-06-15       Impact factor: 3.332

Review 6.  Valium without dependence? Individual GABAA receptor subtype contribution toward benzodiazepine addiction, tolerance, and therapeutic effects.

Authors:  Tianze Cheng; Dominique Marie Wallace; Benjamin Ponteri; Mahir Tuli
Journal:  Neuropsychiatr Dis Treat       Date:  2018-05-23       Impact factor: 2.570

Review 7.  Sugar Addiction: From Evolution to Revolution.

Authors:  David A Wiss; Nicole Avena; Pedro Rada
Journal:  Front Psychiatry       Date:  2018-11-07       Impact factor: 4.157

8.  Pulmonary thrombosis in acute organophosphate poisoning-Case report and literature overview of prothrombotic preconditioning in organophosphate toxicity.

Authors:  Zanina Pereska; Daniela Chaparoska; Niko Bekarovski; Irena Jurukov; Natasha Simonovska; Aleksandra Babulovska
Journal:  Toxicol Rep       Date:  2019-06-15

9.  Targeted Neurotransmitters Profiling Identifies Metabolic Signatures in Rat Brain by LC-MS/MS: Application in Insomnia, Depression and Alzheimer's Disease.

Authors:  Huarong Xu; Zhenru Wang; Lin Zhu; Zhenyu Sui; Wenchuan Bi; Ran Liu; Kaishun Bi; Qing Li
Journal:  Molecules       Date:  2018-09-17       Impact factor: 4.411

10.  The efficacy and safety of auricular point combined with moxibustion for insomnia: A protocol for systematic review and meta-analysis.

Authors:  Rui Jin; Xu Wang; Yubing Lv; Guangnan Xu; Chen Yang; Yang Guo; Xinju Li
Journal:  Medicine (Baltimore)       Date:  2020-10-09       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.